A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard ...
Breakthrough T1D North Texas and Oklahoma, formerly known as JDRF, hosted the Breakthrough T1D Walk at Hunter Park in Tulsa ...
IN A GROUNDBREAKING medical achievement, a 25-year-old woman with Type 1 diabetes (T1D) in China has successfully undergone a ...
The company now expects its annual 2024 revenue to grow between 20% and 21%, up from its previous forecast of 16% to 19% ...
A campaign led by a diabetes expert at the University of Exeter is aiming reduce plastic waste by encouraging patients and doctors to consider ...
NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...
On Sunday, during November's Diabetes Awareness Month, over 1,500 San Diegans walked to raise money to find a cure at the ...
At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...
The S&P 500 added 0.4% on Friday, Nov. 8, posting its highest-ever close to end a momentous week that included an election ...
Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...
There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...
Insulet Co. (NASDAQ:PODD – Get Free Report) shares shot up 10.7% during trading on Friday after BTIG Research raised their price target on the stock from $260.00 to $270.00. BTIG Research currently ...